MAM
Fem Bleach to launch ad campaign created by Law & Kenneth
MUMBAI: Dabur India‘s facial bleach brand Fem has launched a new ad campaign that features Bollywood actor Sonakshi Sinha and her mother Poonam Sinha.
To be launched in early December, the new ad campaign of Fem has been created by Law & Kenneth.
The campaign aims to promote the new range of facial bleaches under the brand Fem.
Dabur India marketing head (skin care) Sanjay Singal said, “Sonakshi Sinha has been advocating the benefits of Fem Bleaches as the route to healthy and safe fairness for over two years now, and has successfully helped in getting more and more people to switch to Fem Bleaches. Fem Bleaches today stand for giving healthy fairness through natural ingredients like Saffron and Pearls. With this campaign, we are establishing Fem‘s new range as being so natural and safe that even mom‘s recommend it for their daughters beauty care needs.”
In the new TVC, Poonam Sinha is seen sharing her natural beauty secrets with Sonakshi Sinha. The duo takes forward Fem‘s message of ‘Long Lasting Healthy Fairness‘ which comes from natural ingredients like Saffron, Pearls and Milk.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
